SGM
TMO icon

Skye Global Management’s Thermo Fisher Scientific TMO Stock Holding History

Skye Global Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.5M Buy
150,500
+32,000
+27% +$15.4M 1.47% 14
2026
Q1 		$58.2M Buy
118,500
+10,500
+10% +$5.7M 1.16% 15
2025
Q4 		$62.6M Hold
108,000
– – 1.15% 16
2025
Q3 		$52.4M Sell
108,000
-38,500
-26% -$17.9M 1.05% 16
2025
Q2 		$59.4M Buy
146,500
+51,500
+54% +$21.5M 1.03% 18
2025
Q1 		$47.3M Sell
95,000
-11,500
-11% -$6.23M 1.26% 17
2024
Q4 		$55.4M Buy
106,500
+46,500
+78% +$25.6M 1.16% 16
2024
Q3 		$37.1M Buy
60,000
+5,000
+9% +$2.96M 0.9% 17
2024
Q2 		$30.4M Sell
55,000
-10,800
-16% -$6.19M 0.69% 18
2024
Q1 		$38.2M Sell
65,800
-42,200
-39% -$23.7M 0.91% 15
2023
Q4 		$57.3M Buy
108,000
+2,000
+2% +$968K 1.64% 9
2023
Q3 		$53.7M Buy
106,000
+22,000
+26% +$11.7M 1.56% 11
2023
Q2 		$43.8M Buy
84,000
+62,000
+282% +$33.5M 1.21% 12
2023
Q1 		$12.7M Buy
+22,000
New +$12.4M 0.41% 18
2022
Q2 		– Sell
-7,000
Closed -$4.13M – 32
2022
Q1 		$4.13M Sell
7,000
-6,500
-48% -$3.73M 0.07% 21
2021
Q4 		$9.01M Sell
13,500
-6,800
-33% -$4.25M 0.15% 32
2021
Q3 		$11.6M Buy
20,300
+7,300
+56% +$4.01M 0.19% 31
2021
Q2 		$6.56M Buy
13,000
+9,600
+282% +$4.53M 0.12% 34
2021
Q1 		$1.55M Sell
3,400
-3,400
-50% -$1.62M 0.03% 50
2020
Q4 		$3.17M Buy
6,800
+4,200
+162% +$1.97M 0.07% 40
2020
Q3 		$1.15M Buy
+2,600
New +$1.07M 0.03% 57
2019
Q2 		– Sell
-2,900
Closed -$794K – 55
2019
Q1 		$794K Buy
+2,900
New +$722K 0.1% 36

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Skye Global Management's TMO Position: Q2 2026 in Review

Skye Global Management increased its Thermo Fisher Scientific (TMO) stake by 27% in Q2 2026, buying an estimated $15.4M and bringing the position to 150,500 shares worth $75.5M. The position accounts for 1.47% of the portfolio, ranked #14.

Skye Global Management first reported a position in TMO in Q1 2019 and has held it in 22 quarters since. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Skye Global Management held 150,500 shares of Thermo Fisher Scientific worth $75.5M as of Q2 2026.
  • Skye Global Management bought 32,000 Thermo Fisher Scientific shares in Q2 2026, an estimated $15.4M.
  • Thermo Fisher Scientific made up 1.47% of Skye Global Management's portfolio in Q2 2026, its #14 holding.
  • Skye Global Management first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 22 quarters since.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Skye Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.